| Bioactivity | Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure[1][2]. |
| Invitro | Mevalonic acid lithium salt (80, 90, 100, 110 µM; 72 h) shows prevention of simvastatin-induced loss of viability of C2C12myotube cells in vitro[1]. Cell Viability Assay[1] Cell Line: |
| Name | Mevalonic acid lithium salt |
| CAS | 2618458-93-6 |
| Formula | C6H11LiO4 |
| Molar Mass | 154.09 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Mevalonic acid lithium salt
CAS: 2618458-93-6 F: C6H11LiO4 W: 154.09
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.